Background: Sepsis is a major disease affecting almost all organs and systems. Objectives: To examine platelet count and indices (mean platelet volume (MPV) and platelet distribution width (PDW)) in severe sepsis. Methods: Patients with criteria for sepsis at a first examination by an Infectious Diseases specialist were selected. Consecutive patients who were admitted to the out-patient clinic and who were not diagnosed with any infectious disease were selected as the control group. Results: A total of 145 patients with sepsis and 143 patients as a control group were included in the study. MPV and PDW were significantly differentbetween sepsis patients and control group (P<0.05). Platelet count in sepsis patients was lower than control group but the difference was not significant. PDW was the unique significantly different parameter between survivors and non-survivors (p=0.001). Conclusions: Platelet indices are important laboratory findings in the diagnosis of sepsis and severe sepsis. Severe sepsis patients who have greater than 18 % PDW levels have a higher risk of death. Therefore, PDW, which is part of an inexpensive, easily accessible and routinely performed test for almost all patients admitted to health facilities may be used for predicting mortality.
Introduction
Sepsis is a major disease affecting millions of people worldwide each year. 1 Approximately 750,000 cases of sepsis per year were seen in the United States (US), and led to 215,000 death. The economic burden of this disease for the US was 16.7 billion US dollars/ year 2 . Almost all organs and systems are affected by sepsis. The haemostatic system is also adversely affected. 3 In sepsis pathophysiology: clotting cascades do not function, many pro-and anti-inflammatory cytokines are released from mononuclear and endothelial cells, thrombus occurs in later stages, and plasminogen stimulation and antithrombin-III activation take place in the fibrinolytic system. 4 As a result, fibrinolytic and fibrinogen substances are depleted, and formation of clots and bleeding associated with disseminated intravascular coagulation (DIC) occur at the same time. In the end, DIC results with increased platelet destruction. 5, 6 There is also peripheral non-immune destruction, hemophagocytic histiocytosis, and marrow suppression, all playing different roles in thrombocytopenia in septic patients. 7 The contribution of thrombocytopenia in severe sepsis has not been clearly established. 3, 7 The normal range of platelet counts in adults is 150,000 -400,000/µL. Higher platelet counts are observed in females than in males 8 . Approximately 40 % of patients with severe sepsis have platelet counts less than 80,000/mm 3 . 7 Decreased platelet counts parallel the severity of infection. 9 Mean platelet volume (MPV) is a measurement of the average size of platelets found in the blood. There are high MPV levels in destructive thrombocytopenia and low MPV levels in hypoproliferative thrombocytopenia 10, 11 . Platelet distribution width (PDW) is an indicator of variation in platelet size. Normal values of PDW are between 10 % and 17.9 %. 12 Easily accessible, inexpensive, and widely used laboratory tests that show the severity of sepsis are important. MPV and PDW are widely and routinely used in clinical practice worldwide. Higher MPV and increased PDW have been found in sepsis. 3 However, the role of these parameters in severe sepsis have not been investigated.
In this study, we aimed to investigate the relationship between severe sepsis and platelet count, MPV, and PDW.
Methods

Study design and Setting
This is a retrospective cohort study that was conducted between September 2011 and May 2012 in a tertiary training and research hospital. Our hospital consists of two campuses (400 +200 bed capacity) with a total of 220 doctors, 315 nurses and 180 auxiliary health personnel. There are two general intensive care units (ICUs) with 10 and five beds, one cardiac ICU with six beds, and one neurological ICU with six beds in our hospital. The infection control team consists of one Infectious Diseases and Clinical Microbiology (IDCM) clinical director, four IDCM specialists and two infection control nurses. IDCM specialists and infection control nurses evaluate the patients in ICU every day and prescribe their antibiotics.
Study group
Patient medical records and the electronic patient data monitoring system were examined retrospectively. Patients diagnosed as sepsis, severe sepsis, and septic shock at the first medical examination by an IDCM specialist were included.
Control Group
Control group/patients were selected from consecutive patients who were admitted to the outpatient clinic. Selection criteria for the control group were: -no infectious disease diagnosis, -normal C-reactive protein (CRP) level in laboratory examination -normal leukocyte count in laboratory examination -no systemic inflammatory response syndrome (SIRS) criteria in his/her medical records
Definitions
The diagnosis of sepsis was made during the first examination. Sepsis was defined as SIRS with a proven or suspected source of infection. SIRS was defined as two or more of the perturbations in table 1 7 . Patients who had organ dysfunction and/or hypoperfusion abnormalities were defined as severe sepsis (table 1) . 1 Thrombocytopenia was defined as a platelet count lower than 150,000/mm 3 . 
Demographic characteristics
Demographic characteristics, such as age, gender, and the reason for hospitalization (medical or surgical) and laboratory results (whole blood count and CRP) at admission were obtained from patient files. Also, patient files were investigated for 28-day mortality. Patients who were discharged within 28 days after diagnosis of sepsis and who continued to have follow-up in the hospital at the 28 th day of patient monitoring were accepted as survivors. Patients who died within the 28 days of patient monitoring were accepted as non-survivors.
Statistical methods
The Kolmogorov-Smirnov test was used to evaluate whether the distribution of variables were normal. Two independent sample t test was used to compare the normal distributed continuous variables between groups. Normal distributed continuous variables were presented as mean ±standard deviation. MannWhitney U test was used to compare the non-normal distributed continuous variables between groups. Non-normal distributed continuous variables were presented as the median and interquartile range (IQR, quartile 1 to 3). Categorical variables were compared by Pearson's or Yates corrected Chi-Square tests. Categorical variables were presented as a count and percentage.
Receiver operating characteristic (ROC) curve analysis was performed to establish the most accurate diagnostic method (biomarker) to discriminate between sepsis and normal. ROC curves were constructed for Platelet, mean platelet volume and platelet distribution Width to test the various biomarkers in predicting sepsis (figure1). The areas under the ROC curves (AUC) were calculated and the specificity, sensitivity, positive-predictive value (PPV), negative-predictive value (NPV), and accuracy, for the platelet, mean platelet volume and platelet distribution Width of the most appropriate cut-off point were calculated for predicting sepsis. A multivariate logistic regression model was implemented to determine Platelet, Mean Platelet volume and Platelet distribution Width and other covariates associated with sepsis. A p-value <0.05 was considered significant. Analyses were performed using commercial software (IBM SPSS Statistics 20, SPSS inc., IBM Co., Somers, NY; MedCalc11, Mariakerke, Belgium). 
Results
A total of 145 sepsis patients were included in this study. The study population consisted of 61 females and 84 males, of which 22 were surgical and 123 medical patients. Also, 143 patients (49 females and 94 males) were included as a control group. Thrombocytopenia was observed in 49 (33.8 %) patients with sepsis and in 4 (2.8 %) patients in the control group (p<0.001). Age and gender were statistically similar between septic patients and the control group (p>0.05). However, a statistically significant difference was found in MPV and PDW Out of 145 sepsis patients, 88 (60.7%) of them were diagnosed as having severe sepsis. Thrombocytopenia was observed in 36 (40.9 %) severe sepsis patients and in 13 (22.8 %) non-severe sepsis patients (p=0.01). While a statistical difference was not found between sepsis and severe sepsis patients in terms of demographic characteristics, CRP, leukocyte, and neutrophil count, there was a meaningful statistical difference in platelet count and their indices as indicated in table 3. 
Discussion
Our findings revealed that MPV and PDW were significant parameters in septic patients. These parameters were higher in septic patients than in controls. In addition, a lower platelet count was observed in septic patients. This situation was due to production of many cytokines, endothelial damage, and bone marrow suppression in septic patients. Our findings indicated that greater MPV levels higher than 8 fl have moderate (53.47 %) sensitivity and good (87.41%) specificity for sepsis diagnosis. Patients with severe sepsis have lower platelet count, higher MPV, and increased PDW compared to patients with sepsis. On the other hand, leukocyte count, neutrophil count and CRP are not useful in a differential diagnosis of sepsis and severe sepsis. Therefore, platelet count and their indices can be used as a direct indicator of organ dysfunction. Findings in a recent study support our results. In that study, low platelet count was found in the first three days of Gram-positive septic patients and in the first four days of Gram-negative sepsis. Similarly, MPV was found to be higher in the first three and five days of Gram-positive sepsis and Gram-negative sepsis, respectively. 13 However, PDW was not reported in that study. In an animal-experiment study, researchers found that PDW was increased in the presence of endotoxemia.
14 In a study conducted in newborns, Patrick et al reported that high levels of MPV and PDW have 95 % and 79 % specificity in the detection of bacteremia, respectively. 15 The present study conducted in adults demonstrated that PDW was higher in sepsis patients, as were MPV levels. Moreover, PDW and MPV levels in severe sepsis patients were higher than in patients with sepsis. It has been demonstrated that coagulation and platelet activation/hyper aggregation can occur in an early phase of sepsis. 3 In order to obtain a larger surface, platelets change their discoid shape to a spherical shape during activation. At the same time, pseudopodia formation occurs. Platelets with increased number and size of pseudopodia may affect the PDW. 16 Platelet volume is related to platelet function and activation as well. Generally, platelet production increases as platelet count decreases. An increased number of young platelets is also functionally more active than older platelets. 17 The low level of thrombocytopenia in patients with severe sepsis can explain the high levels of MPV and PDW.
PDW was the only significant distinctive laboratory parameter different between survivors and non-survivors. The threshold of PDW in estimating death was 18 %. Septic patients who have greater than 18 % PDW have a higher risk of death. In a study that examined 13,701 healthy adults in the United States, among the platelet indices, only PDW, and not platelet count or MPV was found to be an independent predictor of all-cause and cardiovascular mortality. 18 Hence PDW can be used as a parameter in estimating death rate among septic patients.
Conclusion
MPV and PDW are significant parameters in the diagnosis of sepsis and in the differential diagnosis of sepsis and severe sepsis. PDW is an important parameter for estimating the death rate among septic patients. MPV and PDW values in whole blood counts, which is performed for almost all patients admitted to health facilities, should be carefully monitored in patients with sepsis.
